Neurofibromatosis type 2 in childhood: a clinical characterization

被引:1
|
作者
Hinojosa-Mateo, Carmen M. [1 ]
Reche-Sainz, Jose A. [2 ]
Hernandez-Nunez, Almudena [3 ]
Ramos-Lopez, Maria [4 ]
Arpa-Fernandez, Ana [5 ]
Natera-de Benito, Daniel [1 ]
机构
[1] Hosp Univ Fuenlabrada, Serv Pediat, Camino Molino 2, E-28942 Madrid, Spain
[2] Hosp Univ Fuenlabrada, Serv Oftalmol, Madrid, Spain
[3] Hosp Univ Fuenlabrada, Serv Dermatol, Madrid, Spain
[4] Hosp Univ Fuenlabrada, Serv Radiol, Madrid, Spain
[5] Hosp Univ Fuenlabrada, Serv Lab Clin, Madrid, Spain
关键词
Childhood; Congenital cataract; Meningioma; Neurofibromatosis type 2; Schwannoma; Wishart; DIAGNOSIS; MANAGEMENT; NF2;
D O I
10.33588/rn.6403.2016355
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Neurofibromatosis type 2 (NF2) is a dominantly inherited neuroectodermal syndrome that predispose to the development of tumors of the central and peripheral nervous system. Additional features include eye and skin abnormalities. Case report. A 12-year old male with diagnosis of MF2 according to Baser et al and presentation in childhood was included. A comprehensive bibliographic review of evolution of the diagnostic criteria for NF2 in children was performed. Conclusions. The pattern of presentation of NF2 in childhood differs from adulthood in many aspects. Ophthalmologic and skin manifestations, and not an auditory dysfunction, are the most common initial symptoms in prepuberal-onset NF2. The most frequent symptoms and signs at presentation are posterior subcapsular cataract, skin manifestations as NF2 plaques and/ or peripheral nerve tumors, and neurological dysfunction related to isolated or multiple cranial nerve deficits (other than nerve VIII), brainstem masses or spinal masses. As sensitivity of diagnostic criteria in children is low, those prepuberal patients with congenital or early-onset cataracts and typical skin manifestations of NF2 should be systematically assessed.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 50 条
  • [41] Role of Molecular Genetic Factors in Formation of the Clinical Type of Neurofibromatosis Type 2
    K. O. Karandasheva
    E. S. Makashova
    F. A. Ageeva
    K. I. Anoshkin
    P. A. Sparber
    A. O. Borovikov
    P. A. Vasiluev
    M. S. Pashchenko
    A. S. Tanas
    V. V. Strelnikov
    Russian Journal of Genetics, 2024, 60 : 210 - 219
  • [42] Neurofibromatosis type 2
    Uppal, S
    Coatesworth, AP
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (08) : 698 - 703
  • [43] Clinical Presentation of Patients With Neurofibromatosis Type 1 in Infancy and Childhood: Genetic Traits and Gender Effects
    Suenobu, So-ichi
    Akiyoshi, Kensuke
    Maeda, Tomoki
    Korematsu, Seigo
    Izumi, Tatsuro
    JOURNAL OF CHILD NEUROLOGY, 2008, 23 (11) : 1282 - 1287
  • [44] NEUROFIBROMATOSIS TYPE-1 AND CHILDHOOD-CANCER
    MATSUI, I
    TANIMURA, M
    KOBAYASHI, N
    SAWADA, T
    NAGAHARA, N
    AKATSUKA, J
    CANCER, 1993, 72 (09) : 2746 - 2754
  • [45] Development in children with neurofibromatosis type 1 in early childhood
    Krampe-Heni, Franziska
    Fuschlberger, Tamara
    Wahllaender, Ute
    Voigt, Friedrich
    Mall, Volker
    Kraus, Verena
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2025, 55 : 56 - 64
  • [46] Cranial irradiation in childhood mimicking neurofibromatosis type II
    Bokstein, Felix
    Dubov, Tom
    Toledano-Alhadef, Hagit
    Bernstein-Molho, Rinat
    Constantini, Shlomi
    Evans, D. Gareth
    Ben-Shachar, Shay
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2017, 173 (06) : 1635 - 1639
  • [47] LETHAL MANIFESTATIONS OF NEUROFIBROMATOSIS TYPE-1 IN CHILDHOOD
    KOSZYCA, B
    MOORE, L
    BYARD, RW
    PEDIATRIC PATHOLOGY, 1993, 13 (05): : 573 - 581
  • [48] A clinical study of type I neurofibromatosis
    Lozada, Y
    Alvarez-Valiente, H
    Arguelles, M
    REVISTA DE NEUROLOGIA, 1998, 27 (159) : 792 - 795
  • [49] UNUSUAL COURSE OF NEUROFIBROMATOSIS IN CHILDHOOD - CLINICAL AND NEUROPATHOLOGICAL OBSERVATION
    LIPINSKI, CG
    SCHWECHHEIMER, KK
    KLINISCHE PADIATRIE, 1986, 198 (02): : 122 - 125
  • [50] Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients
    Rosenbaum, C
    Kluwe, L
    Mautner, VF
    Friedrich, RE
    Muller, HW
    Hanemann, CO
    NEUROBIOLOGY OF DISEASE, 1998, 5 (01) : 55 - 64